Vor Biopharma Inc. Common Stock — Quarterly Financial Statements (NASDAQ:VOR) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 765.65 M
Employee 76
Founded 2015
CEO N/A
Website www.vorbio.com
Headquarter Massachusetts, United States
FIGI BBG00NBJRDT6
Industry Biotechnology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

Price to earnings ratio

-0.25

Price to sales ratio

-33.84

News

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma: It's A Game Of Wait And See (NASDAQ:VOR)

Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:VOR) 2026-01-16

Micron Tech and Citigroup among market cap stock movers on Wednesday

Vor Biopharma adds two investment partners to board of directors

Vor Biopharma (VOR): Initiating Hold Rating On Durable Telitacicept MG Study Data

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential

Vor Bio raises $150 million in private placement to fund clinical trials

Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price (VOR)

JPMorgan initiates Vor Biopharma stock with Overweight rating on telitacicept potential